Skip to search.
 FTSE 100 Up 0.71%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
5.38 Down 0.08(1.47%) 17:49 - Nasdaq Real Time Price
Prev Close:5.46
Open:5.34
Bid:5.36 x 200
Ask:5.37 x 400
1y Target Est:18.40
Beta:2.57959
Earnings Date:20 Apr - 25 Apr (Est.)
Day's Range:5.06 - 5.74
52wk Range:5.06 - 19.25
Volume:737,889
Avg Vol (3m):1,143,600
Market Cap:376.85m
P/E (ttm):N/A
EPS (ttm):-0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMODown 1.47%376.85m
LLYUp 2.01%79.11b
AMGNUp 2.17%110.28b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.60
Quarterly EPS Est (Dec-15) :-0.21
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback